These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 16699374)

  • 1. IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells.
    Rosenberg SA; Sportès C; Ahmadzadeh M; Fry TJ; Ngo LT; Schwarz SL; Stetler-Stevenson M; Morton KE; Mavroukakis SA; Morre M; Buffet R; Mackall CL; Gress RE
    J Immunother; 2006; 29(3):313-9. PubMed ID: 16699374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.
    Sereti I; Dunham RM; Spritzler J; Aga E; Proschan MA; Medvik K; Battaglia CA; Landay AL; Pahwa S; Fischl MA; Asmuth DM; Tenorio AR; Altman JD; Fox L; Moir S; Malaspina A; Morre M; Buffet R; Silvestri G; Lederman MM;
    Blood; 2009 Jun; 113(25):6304-14. PubMed ID: 19380868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
    Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
    Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-7 promotes human regulatory T cell development at the CD4+CD8+ double-positive thymocyte stage.
    Tuulasvaara A; Vanhanen R; Baldauf HM; Puntila J; Arstila TP
    J Leukoc Biol; 2016 Sep; 100(3):491-8. PubMed ID: 26965634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Activation of Tumor Necrosis Factor Receptor II Induces Antiinflammatory Responses and Alleviates Experimental Arthritis.
    Fischer R; Proske M; Duffey M; Stangl H; Martinez GF; Peters N; Kraske A; Straub RH; Bethea JR; Kontermann RE; Pfizenmaier K
    Arthritis Rheumatol; 2018 May; 70(5):722-735. PubMed ID: 29342501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oscillatory mTOR inhibition and Treg increase in kidney transplantation.
    Sabbatini M; Ruggiero G; Palatucci AT; Rubino V; Federico S; Giovazzino A; Apicella L; Santopaolo M; Matarese G; Galgani M; Terrazzano G
    Clin Exp Immunol; 2015 Nov; 182(2):230-40. PubMed ID: 26077103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8
    Gravano DM; Al-Kuhlani M; Davini D; Sanders PD; Manilay JO; Hoyer KK
    J Autoimmun; 2016 Dec; 75():58-67. PubMed ID: 27453063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of arsenic disulfide on proliferation, cytokine production, and frequencies of CD4(+), CD8(+), and regulatory T cells in mitogen-activated human peripheral blood mononuclear cells.
    Song MM; Fang S; Tanaka S; Sugiyama K; Kiyomi A; Kato R; Onda K; Yuan B; Takagi N; Hu X; Hirano T
    Int Immunopharmacol; 2015 Dec; 29(2):832-838. PubMed ID: 26359544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice.
    Tsark EC; Dao MA; Wang X; Weinberg K; Nolta JA
    J Immunol; 2001 Jan; 166(1):170-81. PubMed ID: 11123290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells.
    Khan S; Burt DJ; Ralph C; Thistlethwaite FC; Hawkins RE; Elkord E
    Clin Immunol; 2011 Jan; 138(1):85-96. PubMed ID: 21056008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.
    Lim A; French MA; Price P
    J Acquir Immune Defic Syndr; 2009 Jul; 51(3):248-57. PubMed ID: 19363449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.
    Pathangey LB; McCurry DB; Gendler SJ; Dominguez AL; Gorman JE; Pathangey G; Mihalik LA; Dang Y; Disis ML; Cohen PA
    Oncotarget; 2017 Feb; 8(7):10785-10808. PubMed ID: 27974697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo depletion of CD4+CD25+ regulatory T cells in cats.
    Smithberg SR; Fogle JE; Mexas AM; Reckling SK; Lankford SM; Tompkins MB; Dean GA
    J Immunol Methods; 2008 Jan; 329(1-2):81-91. PubMed ID: 17980384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
    Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
    Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine and ketamine inhibit immune function of gastric cancer patients by increasing percentage of CD4(+)CD25(+)Foxp3(+) regulatory T cells in vitro.
    Hou M; Zhou NB; Li H; Wang BS; Wang XQ; Wang XW; Wang KG; Xue FS
    J Surg Res; 2016 Jun; 203(2):306-12. PubMed ID: 27363637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Important decrease in invariant natural killer T, CD4+ regulatory T cells, CD8+ regulatory T cells, gamma-delta T cells, and CD4+ T lymphocytes in HIV-negative patients with hemophilia.
    Vela-Ojeda J; Garcia-Chavez J; Majluf-Cruz A; Reyes-Maldonado E; Garcia-Ruiz Esparza MA; Montiel-Cervantes LA
    Blood Coagul Fibrinolysis; 2021 Jan; 32(1):8-15. PubMed ID: 33148947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
    Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes.
    Haller MJ; Gitelman SE; Gottlieb PA; Michels AW; Perry DJ; Schultz AR; Hulme MA; Shuster JJ; Zou B; Wasserfall CH; Posgai AL; Mathews CE; Brusko TM; Atkinson MA; Schatz DA
    Diabetes; 2016 Dec; 65(12):3765-3775. PubMed ID: 27669730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
    Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
    Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.